Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells.

Phipps SM, Love WK, White T, Andrews LG, Tollefsbol TO.

Anticancer Res. 2009 Dec;29(12):4959-64.

2.

Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.

Li Y, Liu L, Andrews LG, Tollefsbol TO.

Int J Cancer. 2009 Jul 15;125(2):286-96. doi: 10.1002/ijc.24398.

3.

Differential expression of epigenetic modulators during human embryonic stem cell differentiation.

Phipps SM, Love WK, Mott TE, Andrews LG, Tollefsbol TO.

Mol Biotechnol. 2009 Mar;41(3):201-7. doi: 10.1007/s12033-008-9118-8. Epub 2008 Oct 25.

4.

The Novel Retinoid, 9cUAB30, Inhibits Telomerase and Induces Apoptosis in HL60 Cells.

Love WK, Deangelis JT, Berletch JB, Phipps SM, Andrews LG, Brouillette WJ, Muccio DD, Tollefsbol TO.

Transl Oncol. 2008 Sep;1(3):148-52.

5.

Retrovirus-mediated RNA interference. Targeting hTERT through stable expression of short-hairpin RNA.

Cunningham AP, Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2007;405:39-46. doi: 10.1007/978-1-60327-070-0_5.

6.

RNA interference using a plasmid construct expressing short-hairpin RNA.

Lai SR, Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2007;405:31-7. doi: 10.1007/978-1-60327-070-0_4.

7.

hTERT knockdown in human embryonic kidney cells using double-stranded RNA.

Lai SR, Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2007;405:23-9. doi: 10.1007/978-1-60327-070-0_3.

8.

Methods of telomerase inhibition.

Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2007;405:1-7. doi: 10.1007/978-1-60327-070-0_1.

9.

Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.

Love WK, Berletch JB, Andrews LG, Tollefsbol TO.

Int J Oncol. 2008 Mar;32(3):625-31.

10.

A method to study the expression of DNA methyltransferases in aging systems in vitro.

Berletch JB, Phipps SM, Walthall SL, Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2007;371:81-7. Review.

11.

A method to detect DNA methyltransferase I gene transcription in vitro in aging systems.

Berletch JB, Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2007;371:73-80. Review.

12.

Aging cell culture: methods and observations.

Phipps SM, Berletch JB, Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2007;371:9-19. Review.

13.

Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.

Berletch JB, Liu C, Love WK, Andrews LG, Katiyar SK, Tollefsbol TO.

J Cell Biochem. 2008 Feb 1;103(2):509-19.

14.
15.

Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop.

Lai SR, Cunningham AP, Huynh VQ, Andrews LG, Tollefsbol TO.

Exp Cell Res. 2007 Jan 15;313(2):322-30. Epub 2006 Oct 25.

16.

Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Cunningham AP, Love WK, Zhang RW, Andrews LG, Tollefsbol TO.

Curr Med Chem. 2006;13(24):2875-88. Review.

17.

Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.

Liu L, Andrews LG, Tollefsbol TO.

Oncogene. 2006 Jul 20;25(31):4370-5. Epub 2006 Feb 27.

18.

The impact of metabolism on DNA methylation.

Ulrey CL, Liu L, Andrews LG, Tollefsbol TO.

Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R139-47. Review.

PMID:
15809266
19.

Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems.

Lai SR, Phipps SM, Liu L, Andrews LG, Tollefsbol TO.

Front Biosci. 2005 May 1;10:1779-96. Review.

PMID:
15769667
20.

Genetic and epigenetic modulation of telomerase activity in development and disease.

Liu L, Lai S, Andrews LG, Tollefsbol TO.

Gene. 2004 Sep 29;340(1):1-10. Review.

PMID:
15556289
21.

Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation.

Liu L, Berletch JB, Green JG, Pate MS, Andrews LG, Tollefsbol TO.

Mol Cancer Ther. 2004 Aug;3(8):1003-9.

22.

Profiling DNA methylation by bisulfite genomic sequencing: problems and solutions.

Liu L, Wylie RC, Hansen NJ, Andrews LG, Tollefsbol TO.

Methods Mol Biol. 2004;287:169-79.

PMID:
15273411
23.

Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation.

Liu L, Saldanha SN, Pate MS, Andrews LG, Tollefsbol TO.

Genes Chromosomes Cancer. 2004 Sep;41(1):26-37.

PMID:
15236314
24.

Aging, cancer and nutrition: the DNA methylation connection.

Liu L, Wylie RC, Andrews LG, Tollefsbol TO.

Mech Ageing Dev. 2003 Dec;124(10-12):989-98. Review.

PMID:
14659588
25.

Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts.

Casillas MA Jr, Lopatina N, Andrews LG, Tollefsbol TO.

Mol Cell Biochem. 2003 Oct;252(1-2):33-43.

PMID:
14577574
26.

Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.

Casillas MA, Brotherton SL, Andrews LG, Ruppert JM, Tollefsbol TO.

Gene. 2003 Oct 16;316:57-65.

PMID:
14563552
27.

Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells.

Lopatina NG, Poole JC, Saldanha SN, Hansen NJ, Key JS, Pita MA, Andrews LG, Tollefsbol TO.

Biochem Biophys Res Commun. 2003 Jul 4;306(3):650-9.

PMID:
12810068
28.

Analysis of telomerase activity and detection of its catalytic subunit, hTERT.

Saldanha SN, Andrews LG, Tollefsbol TO.

Anal Biochem. 2003 Apr 1;315(1):1-21. Review.

PMID:
12672407
29.

Assessment of telomere length and factors that contribute to its stability.

Saldanha SN, Andrews LG, Tollefsbol TO.

Eur J Biochem. 2003 Feb;270(3):389-403. Review.

30.

Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts.

Lopatina N, Haskell JF, Andrews LG, Poole JC, Saldanha S, Tollefsbol T.

J Cell Biochem. 2002;84(2):324-34.

PMID:
11787061
31.

Mechanisms for telomerase gene control in aging cells and tumorigenesis.

Tollefsbol TO, Andrews LG.

Med Hypotheses. 2001 Jun;56(6):630-7.

PMID:
11399111
32.

Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).

Poole JC, Andrews LG, Tollefsbol TO.

Gene. 2001 May 16;269(1-2):1-12. Review.

PMID:
11376932
33.

Identification of specific protein-RNA target sites using libraries of natural sequences.

Andrews LG, Keene JD.

Methods Mol Biol. 1999;118:233-44. No abstract available.

PMID:
10549526
34.

Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes.

Jain RG, Andrews LG, McGowan KM, Pekala PH, Keene JD.

Mol Cell Biol. 1997 Feb;17(2):954-62.

35.

Mutations in purine nucleoside phosphorylase deficiency.

Markert ML, Finkel BD, McLaughlin TM, Watson TJ, Collard HR, McMahon CP, Andrews LG, Barrett MJ, Ward FE.

Hum Mutat. 1997;9(2):118-21.

PMID:
9067751
36.

Hel-N1, an RNA-binding protein, is a ligand for an A + U rich region of the GLUT1 3' UTR.

Jain RG, Andrews LG, McGowan KM, Gao F, Keene JD, Pekala PP.

Nucleic Acids Symp Ser. 1995;(33):209-11.

PMID:
8643372
37.

Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).

Grierson HL, Skare J, Church J, Silberman T, Davis JR, Kobrinsky N, McGregor R, Israels S, McCarty J, Andrews LG, et al.

Am J Med Genet. 1993 Sep 15;47(4):458-63.

PMID:
8256804
38.

Mechanisms for methylation-mediated gene silencing and aging.

Tollefsbol TO, Andrews LG.

Med Hypotheses. 1993 Jul;41(1):83-92.

PMID:
8231986
39.
40.

Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency.

Aust MR, Andrews LG, Barrett MJ, Norby-Slycord CJ, Markert ML.

Am J Hum Genet. 1992 Oct;51(4):763-72.

41.
42.

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ Jr, Green M, Andrews LG, Faich GA.

JAMA. 1990 Apr 4;263(13):1785-8.

PMID:
2313850
43.

Elevated serum alpha-fetoprotein in a pregnant woman with rheumatoid arthritis.

Andrews LG, Souma JA.

N Engl J Med. 1989 Jul 27;321(4):262-3. No abstract available.

PMID:
2473402
44.

Epidemiology of bovine tuberculosis in northern Australia.

Andrews LG, Johnston JH.

Acta Vet Scand Suppl. 1988;84:139-41. No abstract available.

PMID:
3232598
45.

A patient with partial duplication 2q and partial deficiency 11q.

Ho CK, Henderson KC, Bowyer FP, Eilers KB, Andrews LG.

Am J Med Genet. 1987 Nov;28(3):575-9. Review.

PMID:
3322008
46.

Rhode Island physicians' recognition and reporting of adverse drug reactions.

Scott HD, Rosenbaum SE, Waters WJ, Colt AM, Andrews LG, Juergens JP, Faich GA.

R I Med J. 1987 Jul;70(7):311-6. No abstract available.

PMID:
3476980
47.
48.

A system for checking radiation therapy calculations for treatment time or monitor setting.

Anderson DW, Chu WK, Raeside DE, Andrews LG.

Radiol Technol. 1981 Jan-Feb;52(4):424-7.

PMID:
7220857
49.

Spinal cord injuries in children in British Columbia.

Andrews LG, Jung SK.

Paraplegia. 1979 Nov;17(4):442-51.

50.

Comparison of the efficiency of two doses of bovine PPD tuberculin in single caudal fold tests on Australian cattle.

Lepper AW, Carpenter MT, Williams OJ, Scanlan WA, McEwan DR, Andrews LG, Thomas TR, Corner LA.

Aust Vet J. 1979 Jun;55(6):251-6. No abstract available.

PMID:
518418

Supplemental Content

Loading ...
Support Center